More data needed on neonatal microbiome seeding
Microbiome volume 10, Article number: 88 (2022)
A convincing body of epidemiological research has linked birth by Cesarean section (C-section) with an increased risk of infectious and chronic diseases such as autoimmune diseases, asthma, and obesity, and even some cancers [1,2,3,4]. Compared to vaginal delivery, birth by C-section is often associated with alterations in neonatal intestinal microbiota diversity, composition, and developmental trajectories , and thus one hypothesis put forward is that C-section disrupts the vertical transmission of beneficial microbes from the mother to the infant during a critical developmental window [6,7,8]. However, major gaps remain in our understanding of the processes involved in early microbiota initialization and maturation, and a direct link between impaired maternal microbiota transfer at birth and acute or chronic illnesses in infants born by C-section has not been established and mechanistically explained.
Microbiota restoration for infants born by C-section has been proposed, tested for safety in small proof-of-concept clinical trials, and evaluated based on the efficacy to compensate for a lack of maternal microbiota transfer during birth. Proposed therapies include “vaginal seeding”, which is based on the inoculation of newborns with a microbiome sample collected from the mother’s vagina before birth , and maternal fecal microbiota transplantation, i.e. the supplementation of breast milk with a fecal bacterial suspension from the mother . Both approaches are conceptually appealing, as they could reestablish vertical routes of microbial transmission interrupted by C-section and induce substantial and long-term effects on intestinal microbiome development, organization and function in the infants. Not surprisingly, they have received widespread attention in the scientific and lay press, leading parents preparing for C-section to inquire about vaginal seeding options at the hospital or at home . Yet, most medical societies do not recommend the procedures due to the lack of strong data supporting their efficacy [12, 13], and the topic remains controversial.
To contribute to the ongoing debate and provide a knowledge base for a broader scientific, clinical and public discussion of microbiome restoration therapies in infants born by C-section, Microbiome has asked several experts in the field to present their perspectives on the biological mechanisms, clinical relevance and potential for therapeutic restoration of the neonatal microbiome . Here, we identify key questions and knowledge gaps that should be addressed in order to better define microbiome deficits, their link to health outcomes and appropriate clinical intervention strategies in the neonatal patient population.
How important is the birth type for microbiome establishment and maturation in the context of other contributing factors?
Exposure of infants to maternal microbiomes during vaginal birth represents only one of several perinatal and early-life contributors to neonatal microbiota initialization and development. While prenatal microbiota colonization in utero remains controversial and likely non-significant under non-pathological conditions (see Microbiome’s special issue on this topic: ), there may be other, indirect maternal influences during pregnancy on the neonatal microbiota, as probiotic supplementation  or enteric infection  in pregnant mice have been shown to affect offspring immunity. After birth, cross-fostering  and cohousing  in mice, as well as postnatal acquisition of maternal and paternal microbial strains during the first weeks, months and years after birth , and breastfeeding [5, 20] among others, have been shown to affect the trajectory of microbiota maturation and immune system development, and may, at least to some extent, compensate for a lack of maternal microbiota transfer during C-section.
Does C-section temporarily disrupt or permanently impair microbiota development, with immediate or lasting consequences?
Most published studies have reported major compositional microbiota differences between vaginally delivered and C-section infants during the first weeks and months of life that disappear between 2 and 5 years of age, as the infant microbiota matures towards an adult state [5, 7, 21, 22], although some studies have reported detectable microbiota signatures in older (5-7 year-old) children born by C-section [21, 23]. An ecological vacancy in the neonatal microbiota after birth, due to reduced maternal microbiota transfer, could result in immediate metabolic or immune consequences that may increase the risk for acute pathologies, such as increased colonization with opportunistic pathogens  or may affect microbial or human developmental processes with health consequences later in life. Intestinal microbiota maturation in infants born vaginally or by C-section appears to follow distinct, but converging developmental trajectories . Yet experimental data from mice suggest lasting health consequences from even transient compositional microbiota alterations, as antibiotic perturbation during a critical developmental window induced lasting metabolic deficits  and transfer of a wild mice-derived microbiota via fostering or cohousing during early pre-weaning life, protected mice from obesity-associated phenotypes . In addition, compositional similarities at the genus or species level, i.e., the taxonomic resolution typically achieved with 16S rRNA gene amplicon or metagenome sequencing, may obscure microbiota alterations at the strain level. Instead of receiving optimal microbial strains from their mothers, infants born by C-section could obtain alternative, suboptimal strains from other, alternative sources, including nutrition . This could result in acute impaired metabolic capabilities, as strain-specific genotype variations with consequences for oligosaccharides utilization for example, have been reported for maternally transferred dominant and secondary Bifidobacterium strains . It should also be noted that members of the genera Bacteroides and Parabacteroides, which are frequently transferred from mothers during vaginal birth [6, 7, 26, 27], often persist over time in the gut of healthy adults  and persistence patterns of these taxa are strongly linked to family and geography , suggesting a potential for co-evolution of specifically adapted bacterial strains from these genera with the human host, as seen for other bacteria . These transmission and co-evolution processes may be disrupted by C-section birth, potentially resulting in lifelong microbiome alterations.
How does C-section quantitatively affect neonatal microbiome dynamics?
There have only been a few attempts to quantify the neonatal microbiome in terms of absolute intestinal microbial abundances (microbial load), but with unexpected and interesting results. Quantitative fecal microbiota profiling of preterm infants identified bacterial and fungal blooms and extinctions, which would not have been detectable with standard, qualitative microbiota analysis methods such as 16S rRNA gene amplicon sequencing . For example, decreased relative abundances of staphylococci in preterm infants would be wrongfully interpreted as suggesting reduced colonization, when in fact constant absolute abundances of this genus indicated stable colonization in the context of increased overall microbial loads . The impaired transfer of the maternal microbiota during C-section, particularly of intestinal bacteria, has been associated with an increased fecal relative abundance of opportunistic pathogens . However, exposure to the same bacterial species from skin, hospital and other environmental sources may also be expected for other newborns, and vaginally delivered infants do harbor such opportunistic pathogens in their feces, albeit at reduced relative abundances . Thus, increased relative abundances of opportunistic bacteria in infants born by C-section do not necessarily indicate their bloom, but could merely reflect a lack of other intestinal microbes. This distinction may have clinical implications, as a quantitative over-abundance of opportunistic pathogens may be prevented by reducing exposure to these bacteria or depleting them with antibiotics, whereas vaginal seeding or fecal microbiota transfer (FMT)-like treatment therapies would be more suitable to compensate for the absence of commensal bacteria.
Is the maternal vaginal or intestinal microbiota the most important source for neonatal microbiota inoculation?
Vaginal bacteria and maternal vaginal strains constitute only a small and transient fraction of the neonatal intestinal microbiota after birth, whereas intestinal microbes and maternal intestinal strains contribute a larger and more persistent portion [7, 27, 32]. Success in restoring taxonomic fecal microbiota compositions in infants born by C-section, which more closely resemble those of vaginally born infants, including restoring disrupted transmission of intestinal Bacteroides strains, has been reported both for vaginal seeding [9, 33] and maternal fecal microbiota transplantation . It is conceivable that both vaginal and intestinal bacteria exert distinct, non-overlapping influences on the developing neonatal microbiota. However, oral administration of the maternal vaginal microbiota to C-section infants had no discernible effect on microbiota composition and rarely resulted in the engraftment of maternal strains in treated infants . Interestingly, the identification of intestinal bacteria in vaginal fluids at the time of birth  suggests a temporal permeability of vaginal and intestinal microbiome boundaries, which may be evolutionarily intended to facilitate vertical microbiota transfer. It is also noteworthy that Bacteroides strains were among the most frequently engrafted members of the donor microbiota in patients with recurrent Clostridioides difficile infection that received FMT from healthy donors [28, 35], indicating that FMT has the potential to restore microbiota deficiencies in C-section infants even later in life.
In conclusion, limitations in our mechanistic understanding of the microbiome initialization and development process and its resilience to perturbation currently prevent a comprehensive assessment of the acute and lasting functional consequences of C-section for the microbiome and the host, as well as ultimately the health effects of the proposed microbiota restoration therapies.
Decker E, Engelmann G, Findeisen A, Gerner P, Laass M, Ney D, et al. Cesarean delivery is associated with celiac disease but not inflammatory bowel disease in children. Pediatrics. 2010;125:e1433–40.
Cardwell CR, Stene LC, Joner G, Cinek O, Svensson J, Goldacre MJ, et al. Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia. 2008;51:726–35.
Keag OE, Norman JE, Stock SJ. Long-term risks and benefits associated with cesarean delivery for mother, baby, and subsequent pregnancies: Systematic review and meta-analysis. PLoS Med. 2018;15:e1002494.
Stokholm J, Thorsen J, Blaser MJ, Rasmussen MA, Hjelmsø M, Shah S, et al. Delivery mode and gut microbial changes correlate with an increased risk of childhood asthma. Sci Transl Med. 2020;12. Available from: https://doi.org/10.1126/scitranslmed.aax9929
Stewart CJ, Ajami NJ, O’Brien JL, Hutchinson DS, Smith DP, Wong MC, et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. 2018;562:583–8.
Shao Y, Forster SC, Tsaliki E, Vervier K, Strang A, Simpson N, et al. Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature. 2019;574:117–21.
Podlesny D, Fricke WF. Strain inheritance and neonatal gut microbiota development: A meta-analysis. Int J Med Microbiol. 2021;311:151483.
Korpela K, Costea P, Coelho LP, Kandels-Lewis S, Willemsen G, Boomsma DI, et al. Selective maternal seeding and environment shape the human gut microbiome. Genome Res. 2018;28:561–8.
Dominguez-Bello MG, De Jesus-Laboy KM, Shen N, Cox LM, Amir A, Gonzalez A, et al. Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer. Nat Med. 2016;22:250–3.
Korpela K, Helve O, Kolho K-L, Saisto T, Skogberg K, Dikareva E, et al. Maternal Fecal Microbiota Transplantation in Cesarean-Born Infants Rapidly Restores Normal Gut Microbial Development: A Proof-of-Concept Study. Cell. 2020;183:324–34.e5.
Iacobucci G. Sixty seconds on . . . vaginal seeding. BMJ. 2016;352:i1095.
Cunnington AJ, Sim K, Deierl A, Kroll JS, Brannigan E, Darby J. “Vaginal seeding” of infants born by caesarean section. BMJ. 2016;352:i227.
Committee Opinion No. 725 Summary: Vaginal Seeding. Obstet Gynecol. 2017;130:1178–9.
van Best N, Dominguez-Bello MG, Hornef MW, et al. Should we modulate the neonatal microbiome and what should be the goal?. Microbiome. 2022;10:74. https://doi.org/10.1186/s40168-022-01281-4.
Fricke WF, Ravel J. Microbiome or no microbiome: are we looking at the prenatal environment through the right lens? Microbiome. 2021;9:9.
Fonseca W, Malinczak C-A, Fujimura K, Li D, McCauley K, Li J, et al. Maternal gut microbiome regulates immunity to RSV infection in offspring. J Exp Med. 2021;218. Available from: https://doi.org/10.1084/jem.20210235
Lim AI, McFadden T, Link VM, Han S-J, Karlsson R-M, Stacy A, et al. Prenatal maternal infection promotes tissue-specific immunity and inflammation in offspring. Science. 2021;373. Available from: https://doi.org/10.1126/science.abf3002
Daft JG, Ptacek T, Kumar R, Morrow C, Lorenz RG. Cross-fostering immediately after birth induces a permanent microbiota shift that is shaped by the nursing mother. Microbiome. 2015;3:17.
Robertson SJ, Lemire P, Maughan H, Goethel A, Turpin W, Bedrani L, et al. Comparison of Co-housing and Littermate Methods for Microbiota Standardization in Mouse Models. Cell Rep. 2019;27:1910–9.e2.
Fehr K, Moossavi S, Sbihi H, Boutin RCT, Bode L, Robertson B, et al. Breastmilk feeding practices are associated with the co-occurrence of bacteria in mothers’ milk and the infant gut: The CHILD cohort study. Cell Host Microbe. 2020;28:285–97.e4 Elsevier BV.
Roswall J, Olsson LM, Kovatcheva-Datchary P, Nilsson S, Tremaroli V, Simon M-C, et al. Developmental trajectory of the healthy human gut microbiota during the first 5 years of life. Cell Host Microbe. 2021;29:765–76.e3.
Chu DM, Ma J, Prince AL, Antony KM, Seferovic MD, Aagaard KM. Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nat Med. 2017;23:314–26.
Salminen S, Gibson GR, McCartney AL, Isolauri E. Influence of mode of delivery on gut microbiota composition in seven year old children. Gut. 2004;53:1388–9.
Cox LM, Yamanishi S, Sohn J, Alekseyenko AV, Leung JM, Cho I, et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 2014;158:705–21.
Hild B, Dreier MS, Oh JH, McCulloch JA, Badger JH, Guo J, et al. Neonatal exposure to a wild-derived microbiome protects mice against diet-induced obesity. Nat Metab. 2021;3:1042–57.
Yassour M, Jason E, Hogstrom LJ, Arthur TD, Tripathi S, Siljander H, et al. Strain-Level Analysis of Mother-to-Child Bacterial Transmission during the First Few Months of Life. Cell Host Microbe. 2018;24:146–54.e4.
Ferretti P, Pasolli E, Tett A, Asnicar F, Gorfer V, Fedi S, et al. Mother-to-Infant Microbial Transmission from Different Body Sites Shapes the Developing Infant Gut Microbiome. Cell Host Microbe. 2018;24:133–45.e5.
Podlesny D, Arze C, Dörner E, Verma S, Dutta S, Walter J, et al. Metagenomic strain detection with SameStr: identification of a persisting core gut microbiota transferable by fecal transplantation. Microbiome. 2022;10:53.
Hildebrand F, Gossmann TI, Frioux C, Özkurt E, Myers PN, Ferretti P, et al. Dispersal strategies shape persistence and evolution of human gut bacteria. Cell Host Microbe. 2021;29:1167–76.e9.
Moodley Y, Linz B, Bond RP, Nieuwoudt M, Soodyall H, Schlebusch CM, et al. Age of the association between Helicobacter pylori and man. PLoS Pathog. 2012;8:e1002693.
Rao C, Coyte KZ, Bainter W, Geha RS, Martin CR, Rakoff-Nahoum S. Multi-kingdom ecological drivers of microbiota assembly in preterm infants. Nature. 2021;591:633–8.
Mitchell CM, Mazzoni C, Hogstrom L, Bryant A, Bergerat A, Cher A, et al. Delivery Mode Affects Stability of Early Infant Gut Microbiota. Cell Rep Med. 2020;1:100156.
Song SJ, Wang J, Martino C, Jiang L, Thompson WK, Shenhav L, et al. Naturalization of the microbiota developmental trajectory of Cesarean-born neonates after vaginal seeding. Med. 2021;2:951–64.e5 Elsevier BV.
Wilson BC, Butler ÉM, Grigg CP, Derraik JGB, Chiavaroli V, Walker N, et al. Oral administration of maternal vaginal microbes at birth to restore gut microbiome development in infants born by caesarean section: A pilot randomised placebo-controlled trial. EBioMedicine. 2021;69:103443.
Smillie CS, Sauk J, Gevers D, Friedman J, Sung J, Youngster I, et al. Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation. Cell Host Microbe. 2018;23:229–40.e5.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Fricke, W.F., Ravel, J. More data needed on neonatal microbiome seeding. Microbiome 10, 88 (2022). https://doi.org/10.1186/s40168-022-01282-3